Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation
Hans F. A. Vasen(Leiden University Medical Center), Wouter H. de Vos tot Nederveen Cappel(Isala), Nelleke A. Gruis(Leiden University), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), G. Johan A. Offerhaus(Amsterdam UMC Location University of Amsterdam), Bert A. Bonsing(Leiden University Medical Center), Martin N.J.M. Wasser(Leiden University Medical Center), Anneke van Mil(Leiden University Medical Center), Marja Konstantinovski(Netherlands Consortium for Healthy Ageing), Hans Morreau(Leiden University Medical Center), Daniël W. Hommes(InterScience (United States)), Wilma Bergman(Leiden University Medical Center), Frederik J. Hes(Leiden University Medical Center)
Cited by 153
Related Papers
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
The Molecular Basis of Turcot's Syndrome
|New England Journal of Medicine|1995|1.1k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k